Global Pain Management Drugs Market Analysis & Industry Forecast 2017-2023, With an Expected CAGR of 4% - ResearchAndMarkets.com

DUBLIN--()--The "Pain Management Drugs Market by Drug Class and Indication - Global Opportunity Analysis and Industry Forecast, 2017-2023" report has been added to ResearchAndMarkets.com's offering.

The global pain management drugs market was valued at $58,577 million in 2016, and is estimated to reach $77,131 million by 2023, registering a CAGR of 4% from 2017 to 2023.

Pain management is a branch of medicine which employs approach to ease the suffering and improve the quality of life of individuals suffering from pain. Pain can be classified based on its occurrence and duration along with the affected body part. First line of treatment for pain management is pharmaceutical therapeutics or pain killer drugs, most of which are well-known brands.

Rise in geriatric population is the major factor that drives the growth of the global pain management market, as aged people are more prone to suffer from joint pain and other chronic conditions. Moreover, surge in prevalence of chronic diseases such as cancer, diabetic neuropathy, and osteoarthritis propels the market growth.

Furthermore, increase in number of surgical procedures and rise in healthcare expenditure are expected to fuel the growth of the market. However, drug exploitation, patent expiration of prescription pain medication drugs, and availability of substitutes such as pain relief devices restrain the market growth.

The global pain management drugs market is segmented based on drug class, indication, and geography. On the basis of drug class, the market is categorized into nonsteroidal anti-inflammatory drugs (NSAIDs), anesthetics, anticonvulsants, antimigraine agents, antidepressants, opioids, and nonnarcotic analgesics. Opioids are further classified into tramadol, hydrocodone, oxycodone, and others.

Companies Mentioned:

  • Novartis AG
  • Eli Lilly & Company
  • Abbott Laboratories
  • Endo Health Solutions, Inc.
  • Purdue Pharma L.P.
  • Pfizer, Inc.
  • F. Hoffmann La Roche Ltd.
  • Merck & Co. Inc.
  • Johnson & Johnson
  • GlaxoSmithKline Plc.

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Market Overview

4 Pain Management Drugs Market, by Drug Type

5 Pain Management Drugs Market, by Indication

6 Pain Management Drugs Market, by Geography

7 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/ksql7v/global_pain?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Analgesics

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Analgesics